Experience of Using a Bruton Tyrosine Kinase (BTK) Inhibitor in Primary Testicular Diffuse Large B-Cell Lymphoma (DLBCL) with Isolated Central Nervous System (CNS) Metastasis
This case highlights the successful use of the MAR regimen and acalabrutinib maintenance in a patient with CNS-relapse PT-DLBCL. Further studies are needed to develop standardized treatment protocols for such high-risk cases.
Authors
- Santhosh Meedimale
Institutions
- Siksha O Anusandhan University (IN)
- Institute of Medical Sciences and Sum Hospital (IN)
Publication Details
- Journal
- Journal of Clinical Practice and Research
- Published
- 2025-01-01
- DOI
- https://doi.org/10.14744/cpr.2025.96241
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00